Related Experiment Video
Updated: Jul 15, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Detecting Adverse Events Following Acute Care Encounters among Veterans Prescribed Non-Steroidal Anti-Inflammatory
Amber J Hackstadt1,2, Amy M Perkins1,2, Jesse O Wrenn3,4,5
1Geriatric Research Education and Clinical Care Center (GRECC) & VETWISE-LHS COIN, Tennessee Valley Healthcare System VA, Nashville, Tennessee, USA.
Objectives:
To model the occurrence of adverse events (AEs) among Veterans prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) during emergency department and urgent care encounters within the Veterans Health Administration (VHA) care setting. NSAIDs can increase the risk for gastrointestinal, renal, and cardiovascular AEs, particularly in older adults, patients with chronic kidney disease (CKD), or patients with polypharmacy.
Methods:
We applied eXtreme Gradient Boosting (XGBoost) modeling and least absolute shrinkage and selection operator (LASSO) methods along with logistic regression to model the occurrence of AEs in a cohort of Veterans prescribed NSAIDs seen between January 1, 2017, and December 31, 2023. The outcome was defined as a composite of acute coronary syndrome, acute kidney injury, allergic reactions, gastrointestinal bleeding, or gastroesophageal reflux disease (GERD) within 2 to 30 days following the encounter. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) values and calibration plots. Observed-to-expected (OE) ratios for AEs were calculated.
Results:
We identified 1,112,819 acute care encounters for 736,677 unique patients and a total of 50,278 (4.5%) AEs. The XGBoost and LASSO regression models performed well across time, with AUC values ranging from 0.77 to 0.79. GERD and a diagnosis of CKD stage 4 or 5/dialysis were identified as having a harmful association with AEs. The OE ratios varied by VHA care site.
Conclusions:
The risk adjustment models had good discrimination performance across time and allowed us to identify significant risk-adjusted site variation. The models may be useful in clinical decision support and population health interventions with NSAIDs.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Therapeutic Drug Monitoring: Affecting Factors
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Therapeutic Drug Monitoring: Overview and Classification